Sanjivani Paranteral Limited (BOM:531569)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Manufacturing Pharmaceutical Products	686.66M	700.99M	544.11M	354.92M	306.13M
Manufacturing Pharmaceutical Products Growth	-2.04%	28.83%	53.31%	15.94%	21.96%
Total	686.66M	700.99M	544.11M	354.92M	306.13M
Total Growth	-2.04%	28.83%	53.31%	15.94%	21.96%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
India	110.29M	76.81M	168.61M	84.73M
India Growth	43.59%	-54.45%	99.00%	-6.01%
Export	525.31M	400.61M	226.53M	192.22M
Export Growth	31.13%	76.85%	17.85%	36.69%
Unallocated	65.39M	66.69M	-40.22M	29.18M
Unallocated Growth	-1.95%	-	-	44.29%
Total	700.99M	544.11M	354.92M	306.13M
Total Growth	28.83%	53.31%	15.94%	21.96%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error